US 7378553
Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards
granted A61PA61P25/00A61P43/00
Quick answer
US patent 7378553 (Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/00, A61P43/00